tiprankstipranks
Damora Therapeutics (DMRA)
NASDAQ:DMRA
US Market
DMRA
Damora Therapeutics
RESEARCH TOOLSreports
Want to see DMRA full AI Analyst Report?

Damora Therapeutics (DMRA) Financial Statements

325 Followers

Damora Therapeutics Financial Overview

Damora Therapeutics's market cap is currently $1.44B. The company's EPS TTM is $; its P/E ratio is -0.04; Damora Therapeutics is scheduled to report earnings on April 24, 2026, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ 0.00$ -181.00K$ -830.00K$ -490.00K$ -441.00K
Operating Income$ -210.87M$ -16.90M$ -36.46M$ -61.21M$ -52.23M
EBITDA$ -210.84M$ -16.72M$ -35.63M$ -60.72M$ -51.79M
Net Income$ -209.84M$ -21.44M$ -38.35M$ -61.62M$ -51.75M
Balance Sheet
Cash & Short-Term Investments$ 257.62M$ 14.18M$ 33.15M$ 60.22M$ 100.19M
Total Assets$ 260.53M$ 17.13M$ 38.23M$ 73.19M$ 122.22M
Total Debt$ 68.00K$ 1.43M$ 249.00K$ 804.00K$ 847.00K
Net Debt$ -257.56M$ -12.74M$ -21.22M$ -31.98M$ -61.72M
Total Liabilities$ 20.15M$ 2.66M$ 5.90M$ 11.44M$ 4.99M
Stockholders' Equity$ 240.38M$ 14.47M$ 32.33M$ 61.75M$ 117.22M
Cash Flow
Free Cash Flow$ -6.73M$ -18.62M$ -36.91M$ -43.13M$ -52.53M
Operating Cash Flow$ -6.73M$ -18.62M$ -36.91M$ -42.93M$ -52.31M
Investing Cash Flow$ -17.37M$ 11.65M$ 22.33M$ 12.38M$ -48.05M
Financing Cash Flow$ 266.84M$ 0.00$ 2.88M$ 507.00K$ 0.00
Currency in USD

Damora Therapeutics Earnings and Revenue History

Income Statement >

Damora Therapeutics Debt to Assets

Balance Sheet >

Damora Therapeutics Cash Flow

Cash Flow >

Damora Therapeutics Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
Earnings >